Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Shire PLC (NASDAQ:SHPG)

166.03
Delayed Data
As of Jun 24
 -14.26 / -7.91%
Today’s Change
147.60
Today|||52-Week Range
270.63
-19.01%
Year-to-Date
Trade-Ideas: Shire (SHPG) Is Today's Pre-Market Mover With Heavy Volume Stock
Jun 24 / TheStreet.com - Paid Partner Content
Shire Buys Global Rights to Pfizer's Gastrointestinal Drug
Jun 15 / Zacks.com - Paid Partner Content
3 Stocks Pulling The Drugs Industry Downward
Jun 21 / TheStreet.com - Paid Partner Content
Shire Gets Breakthrough Status for Rare Disease Candidates
Jun 14 / Zacks.com - Paid Partner Content
Shire (SHPG) Leads The Pack In Pre-Market Activity
Jun 20 / TheStreet.com - Paid Partner Content
Burberry CEO gets 75% pay cut
Jun 06 / CNNMoney.com

Today’s Trading

Previous close180.29
Today’s open168.10
Day’s range165.61 - 172.08
Volume4,555,285
Average volume (3 months)2,865,363
Market cap$32.8B
Dividend yield0.82%
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-61.89%
Earnings growth (this year)+9.51%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+6.79%
P/E ratio24.6
Price/Sales6.33
Price/Book3.33

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-10.58-8.56%
ZTSZoetis Inc-1.39-2.90%
MYLMylan NV-2.60-5.63%
VRTXVertex Pharmaceutica...-6.30-7.14%
Data as of 4:02pm ET, 06/24/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$3.09
Annual revenue (last year)$6.4B
Annual profit (last year)$1.3B
Net profit margin20.84%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs